QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-buy-on-definitive-healthcare-raises-price-target-to-6

Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises the price target from $5 to $6.

 definitive-healthcare-raises-fy2025-adj-eps-guidance-from-020-023-to-022-023-vs-021-est-raises-fy2025-sales-guidance-from-234000m-240000m-to-237000m-240000m-vs-237041m-est

Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 analyst estimate. Rai...

 definitive-healthcare-sees-q3-adj-eps-005-006-vs-006-est-sees-sales-59000m-60000m-vs-59215m-est

Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 mil...

 definitive-healthcare-q2-adj-eps-007-beats-005-estimate-sales-60750m-beat-59200m-estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $...

 goldman-sachs-maintains-neutral-on-definitive-healthcare-raises-price-target-to-34

Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and raises the price target fro...

 definitive-healthcare-raises-fy25-outlook-adj-eps-from-019-022-to-020-023-vs-021-est-sales-from-23000m-24000m-to-23400m-24000m-vs-23428m-est

Full Year 2025:  Revenue is expected to be in the range of $234.0 – $240.0 million, raising the bottom end of our prior range b...

 definitive-healthcare-sees-q2-adj-eps-004-005-vs-005-est-sees-sales-58500m-60000m-vs-5829m-est

Second Quarter 2025:  Revenue is expected to be in the range of $58.5 – $60.0 million. Adjusted Operating Income is expected to...

 definitive-healthcare-q1-adj-eps-005-beats-002-estimate-sales-5919m-beat-5618m-estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $...

 goldman-sachs-maintains-neutral-on-definitive-healthcare-lowers-price-target-to-3

Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and lowers the price target fro...

 barclays-maintains-underweight-on-definitive-healthcare-lowers-price-target-to-3

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from...

 definitive-healthcare-sees-q1-adj-eps-002-vs-007-est-sees-sales-55500m-57000m-vs-5994m-est

Definitive Healthcare (NASDAQ:DH) is looking for Q1 Adj EPS of $0.02 vs $0.07 analyst estimate. sees sales of $55.500 million-$...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION